Nusano
  • Home
  • Company
    • Leadership
    • West Valley City
  • Technology
  • News
  • Careers
  • Contact Us
Select Page
Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

by Scott Larrivee | Apr 20, 2023 | News

NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...

Recent Posts

  • Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
  • Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
  • Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day
  • Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals
  • Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Recent Comments

No comments to show.
Supplying the fight against cancer.
  • Follow
Company
about us
Leadership
Contact us
technology
Proprietary tech
Applications
Investors
Resources
News
Careers
Suppliers
© 2023 Nusano | Web design
Privacy Policy – Terms of Service